News and Trends 25 Nov 2024 Evotec on the brink of acquisition: At what cost for the biotech industry? As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech landscape. November 25, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2024 Eight areas where gene therapy shines Delve into the numerous applications of gene therapy, from cancer to hematological disorders and respiratory diseases. November 21, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 18 Nov 2024 What is Abcam’s founder, Jonathan Milner, up to? Since Abcam was acquired in December 2023, its founder, Jonathan Milner has been very active. Delve into his investment strategy. November 18, 2024 - 17 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Expert Advice 15 Nov 2024 How biotech startups become unicorns Delve into what differentiates a successful biotech startup from a unicorn reaching a $1 billion valuation. November 15, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2024 8 biotech companies advancing new treatments for breast cancer in 2024 Delve into the diverse landscape of breast cancer treatment with nine biotech companies currently developing new treatments. November 14, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Expert Advice 8 Nov 2024 How to negotiate your job offer in biotech Learn how to be prepared to negotiate your biotech job offer by reading the tips that experts shared with us. November 8, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2024 From consumer health to pure biopharma: Inside Sanofi’s strategic shift Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment. November 5, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 1 Nov 2024 Can AI cure Alzheimer’s disease? A couple of weeks back, we took a look at how artificial intelligence (AI) has had a transformative impact on cancer research. Today, we take a look at how AI tools help tackle another formidable challenge of modern biotech, Alzheimer’s disease. “Alzheimer’s is an incredibly complex disease with numerous factors at play. You have the […] November 1, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 31 Oct 2024 Halloween biotech stories: Unveiling scientists’ worst fears What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress. October 31, 2024 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2024 Fighting severe epilepsies: A new era for Dravet syndrome treatment? Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline. October 24, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 21 Oct 2024 Turning back time with cellular reprogramming: Shift raises $16 million in seed funding As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases. October 21, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 18 Oct 2024 The AI boom in cancer: Game-changer or just hype? Is AI just hype or a game-changer? Delve into AI’s contribution to oncology, from diagnostics to drug discovery and personalized treatment. October 18, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email